Sign in
4

Changes in Ownership

NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-012654

CHIEF EXECUTIVE OFFICER bought 50,000 shares at $1.17 ($58,500)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Willard Stephen H CHIEF EXECUTIVE OFFICER 2022-12-16 Purchase +50,000 $1.17 $58,500 50,000 D: show line 1 in the form
Open-market purchases · 50,000 sh · avg $1.17 · $58,500
Loading xslF345X03/form4-12192022_121215.xml…